{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9775444", "DateCompleted": {"Year": "1998", "Month": "11", "Day": "12"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "06"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0009-2363", "JournalIssue": {"Volume": "46", "Issue": "9", "PubDate": {"Year": "1998", "Month": "Sep"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "Potent anticonvulsant paeonimetabolin-I derivatives obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis.", "Pagination": {"StartPage": "1486", "EndPage": "1487", "MedlinePgn": "1486-7"}, "Abstract": {"AbstractText": ["Seventeen thiopaeonimetabolin-I adducts were obtained as mixtures of diastereoisomers after incubation of paeoniflorin with Lactobacillus brevis in the presence of various thiols. Four compounds, 8-(n-hexylthio)- (8), 8-cyclopentylthio-, 8-(p-tolyl)thio- and 8-benzoylthio- (18) paeonimetabolins, showed 100% protection against pentylenetetrazole-induced convulsions at doses of 0.125, 0.25, or 0.50 mmol/kg, relative to valproic acid (100% protection at 1.5 mmol/kg). For 8 and 18, the principle anticonvulsant activity resided in the (7S)-isomers while (7R)-isomers showed muscle relaxation effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Wakan-Yaku, Toyama Medical and Pharmaceutical University, Japan."}], "LastName": "Abdel-Hafez", "ForeName": "A A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Meselhy", "ForeName": "M R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nakamura", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hattori", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Watanabe", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mohamed", "ForeName": "T A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mahfouz", "ForeName": "N M", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "el-Gendy", "ForeName": "M A", "Initials": "MA"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoates"}, {"RegistryNumber": "0", "NameOfSubstance": "Bridged-Ring Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Monoterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfhydryl Compounds"}, {"RegistryNumber": "21AIQ4EV64", "NameOfSubstance": "peoniflorin"}, {"RegistryNumber": "614OI1Z5WI", "NameOfSubstance": "Valproic Acid"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "therapeutic use"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": [], "DescriptorName": "Benzoates"}, {"QualifierName": [], "DescriptorName": "Bridged-Ring Compounds"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glucosides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lactobacillus"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Monoterpenes"}, {"QualifierName": [], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Seizures"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sulfhydryl Compounds"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Valproic Acid"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "10", "Day": "17"}, {"Year": "1998", "Month": "10", "Day": "17", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "10", "Day": "17", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9775444", "10.1248/cpb.46.1486"]}}]}